As innovations and discoveries in cancer immunotherapies progress at lightning speed, it is critical to understand the successes and challenges with current immunotherapies to separate the hype from the real opportunities. IBC's Immuno-Oncology event develops tactics for improving the efficacy and response rates with first generation immunotherapies and builds a strategy for utilizing combination therapies, t-cell therapies, and checkpoint inhibitors to propel the next wave of cancer immunotherapies.
Download the Immuno-Oncology brochure now to create your pathway for an answer to cancer: http://bit.ly/1O6tbIZ
Advancing the Next Generation of Cancer Immunotherapies
September 30 – October 1, 2015
Hilton Alexandria Mark Center, Alexandria, VA
Register today and explore the latest advances in Immuno-Oncology to:
Develop next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies
Create a successful combination therapy strategy by gaining insights from global leaders on effective combinations
Optimize the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies
Download the brochure for full program details: http://bit.ly/1O6tbIZ
Reserve your seat now. Use code IMMUNO15BL to get $100 off the current rate. Register today: http://bit.ly/1O6tbIZ
The Immuno-Oncology Team 2015
Share this article with your social network, just click below to share now!